ATE74126T1 - D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum. - Google Patents

D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.

Info

Publication number
ATE74126T1
ATE74126T1 AT88300710T AT88300710T ATE74126T1 AT E74126 T1 ATE74126 T1 AT E74126T1 AT 88300710 T AT88300710 T AT 88300710T AT 88300710 T AT88300710 T AT 88300710T AT E74126 T1 ATE74126 T1 AT E74126T1
Authority
AT
Austria
Prior art keywords
prostaglandins
tranquilizers
hypnotics
applications
soporifics
Prior art date
Application number
AT88300710T
Other languages
German (de)
English (en)
Inventor
Ryuzo Ueno
Ryuji Ueno
Ichie Kato
Tomio Oda
Original Assignee
Ueno Seiyaku Oyo Kenkyujo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo Kk filed Critical Ueno Seiyaku Oyo Kenkyujo Kk
Application granted granted Critical
Publication of ATE74126T1 publication Critical patent/ATE74126T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT88300710T 1987-01-28 1988-01-28 D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum. ATE74126T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1882187 1987-01-28
EP88300710A EP0281239B1 (en) 1987-01-28 1988-01-28 Prostaglandins of the d series, and tranquilizers and soporifics containing the same

Publications (1)

Publication Number Publication Date
ATE74126T1 true ATE74126T1 (de) 1992-04-15

Family

ID=11982228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88300710T ATE74126T1 (de) 1987-01-28 1988-01-28 D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.

Country Status (8)

Country Link
US (3) US5073569A (en:Method)
EP (1) EP0281239B1 (en:Method)
KR (1) KR930006201B1 (en:Method)
AT (1) ATE74126T1 (en:Method)
CA (1) CA1322749C (en:Method)
DE (1) DE3869444D1 (en:Method)
ES (1) ES2032956T3 (en:Method)
GR (1) GR3004281T3 (en:Method)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
DE3850676T2 (de) * 1987-09-18 1994-11-03 Ueno Seiyaku Oyo Kenkyujo Kk Hypotensive okulare Mittel.
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP1224934A3 (en) * 1988-09-06 2003-03-26 Pharmacia AB Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
CA2022372C (en) * 1989-08-09 2000-05-02 Ryuji Ueno Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
TW249226B (en:Method) * 1990-04-04 1995-06-11 Aderk Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DK0503887T3 (da) * 1991-03-14 1996-09-16 R Tech Ueno Ltd Fremme af sårheling med 15-ketoprostaglandinforbindelser
PT1083168E (pt) 1998-05-25 2004-03-31 Taisho Pharmaceutical Co Ltd Derivado de prostaglandina
AR030275A1 (es) 2000-03-24 2003-08-20 Sucampo Pharmaceuticals Inc Composicion que inhibe la apoptosis y uso de un compuesto 15-ceto-prostaglandina- para producirla
AU2001244727B2 (en) * 2000-04-06 2006-08-10 Sucampo Ag Bile secretion promoting composition
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
NZ531503A (en) 2001-08-31 2006-01-27 Sucampo Ag Prostaglandin analogs as chloride channel opener
US8114911B2 (en) * 2002-10-23 2012-02-14 Sucampo Ag Prostaglandin compounds for the treatment of obesity
KR20120045051A (ko) 2002-12-27 2012-05-08 수캄포 아게 복부 불쾌감 치료용 프로스타글랜딘의 유도체
JP5294559B2 (ja) * 2003-07-03 2013-09-18 スキャンポ・アーゲー クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
KR101118935B1 (ko) 2003-08-21 2012-03-13 가부시키가이샤 아루떼꾸 우에노 안과용 조성물
JP4690814B2 (ja) * 2004-08-02 2011-06-01 株式会社アールテック・ウエノ プロスタグランジン誘導体の製造法
PT1841433E (pt) 2005-01-27 2012-02-01 Sucampo Ag Composição para o tratamento de distúrbios do sistema nervoso central
DK1853271T3 (da) 2005-03-04 2011-01-24 Sucampo Ag Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
RU2468800C2 (ru) * 2005-04-12 2012-12-10 Сукампо Аг Комбинированное применение производного простагландина и ингибитора протонового насоса для лечения желудочно-кишечных заболеваний
JP4783794B2 (ja) * 2006-01-24 2011-09-28 株式会社アールテック・ウエノ 軟ゼラチンカプセル製剤
AU2007208637B2 (en) * 2006-01-24 2012-04-26 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
NZ571426A (en) * 2006-03-13 2011-02-25 R Tech Ueno Ltd Aqueous composition comprising castor oil, a 15-keto-prostaglandin compound and a quaternary ammonium cationic surface active agent
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
WO2012137987A1 (en) 2011-04-07 2012-10-11 Sucampo Ag Method for treating asthenopia
CA2842455A1 (en) * 2011-08-05 2013-02-14 Sucampo Ag Method for treating schizophrenia
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
AR105029A1 (es) 2015-06-19 2017-08-30 Sucampo Ag Composición farmacéutica que comprende derivado de ácido graso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins
DE3850676T2 (de) * 1987-09-18 1994-11-03 Ueno Seiyaku Oyo Kenkyujo Kk Hypotensive okulare Mittel.

Also Published As

Publication number Publication date
KR880008986A (ko) 1988-09-13
US5534547A (en) 1996-07-09
CA1322749C (en) 1993-10-05
DE3869444D1 (de) 1992-04-30
EP0281239A2 (en) 1988-09-07
US5137915A (en) 1992-08-11
US5073569A (en) 1991-12-17
GR3004281T3 (en:Method) 1993-03-31
EP0281239A3 (en) 1988-09-21
KR930006201B1 (ko) 1993-07-08
EP0281239B1 (en) 1992-03-25
ES2032956T3 (es) 1993-03-01

Similar Documents

Publication Publication Date Title
ATE74126T1 (de) D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.
DE3871751D1 (de) Gelbildende organosiloxanzusammensetzungen und deren verwendung.
DE69009636D1 (de) Belastungsregelung und Verfahren.
DE3853191D1 (de) Arzneimittelträger.
DE3851132D1 (de) Polymerteilchen und ihre Herstellung.
DE3884453D1 (de) Homogene additionscopolymere von ethylen und cycloolefinmonomeren und deren herstellung.
DE3789761D1 (de) Reibungsmaterialien und Herstellung derselben.
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
DE69000467D1 (de) Bis-aza-bicyclische anxiolytica und antidepressiva.
DE3882392D1 (de) Kondensations-copolymere, die farbstoffe des typs 2,5-diarylaminoterephthalsaeure enthalten und produkte daraus.
DE3767400D1 (de) Biozide zusammensetzungen und deren verwendung.
DE69010141D1 (de) Lager und Lageranordnung.
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
DE68917352D1 (de) Trimethylolheptane und ihre Anwendung.
DE3684700D1 (de) Hochfunktionelle fluorierte polyisocyanate und daraus hergestellte klarlacke.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
PT85396B (de) Neue 1,4-benzodiazepine ihre herstellung und verwendung
DE3766441D1 (de) Anilinotriazine und deren verwendung.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE69012298D1 (de) Heizen von Lagern und dergleichen.
DE3763939D1 (de) Nadimido-substituierte cyclophosphazene und hitzegehaertete gegenstaende.
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE3875199D1 (de) Dispergiermittel und dieses enthaltende feststoffsuspension.
DE3880307D1 (de) Perfluoralkene und fluorierungsprodukte davon.
DE69012929D1 (de) Phosphitverbindung und deren anwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee